Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Pascal

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Journal of Vascular and Interventional Radiology : JVIR|October 21, 2000
Transjugular intrahepatic portosystemic shunts in the treatment of refractory ascites: results in 48 consecutive patientsJ M Péron, K Barange, P Otal, et al.
British Journal of Clinical Pharmacology|May 1, 1996
Haemodynamic effects of molsidomine and propranolol in patients with cirrhosisJ M Combis, J P Vinel, P Badia, et al.
Journal of the American Society of Nephrology : JASN|December 16, 1998
Pharmacokinetics of alphaIFN-2b in chronic hepatitis C virus patients undergoing chronic hemodialysis or with normal renal function: clinical implicationsL Rostaing, E Chatelut, J L Payen, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1993
[Treatment of hemorrhages by rupture of cardio-tuberous varices with transjugular intrahepatic portasystemic shunt]P Kuradusenge, H Rousseau, J P Vinel, et al.
Hepatology (Baltimore, Md.)|October 26, 1999
Transjugular intrahepatic portosystemic shunt in the treatment of refractory bleeding from ruptured gastric varicesK Barange, J M Péron, K Imani, et al.
Journal of Medical Virology|March 13, 1998
Baseline level and early suppression of serum HCV RNA for predicting sustained complete response to alpha-interferon therapyJ Izopet, J L Payen, L Alric, et al.
Gut|April 1, 1993
Diffuse vascular ectasia of the antrum, duodenum, and jejunum in a patient with nodular regenerative hyperplasia. Lack of response to portosystemic shunt or gastrectomyP Calès, J J Voigt, J L Payen, et al.
Journal of Hepatology|August 1, 1993
Hemodynamic and pharmacokinetic study of tertatolol in patients with alcoholic cirrhosis and portal hypertensionP Calès, H Caillau, O Crambes, et al.
Hepatology (Baltimore, Md.)|June 1, 1991
Systemic and splanchnic hemodynamic effects of molsidomine in rats with carbon tetrachloride-induced cirrhosisH Desmorat, J P Vinel, O Lahlou, et al.
Gastroenterology|November 14, 1997
Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infectionL Alric, M Fort, J Izopet, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Journal of Vascular and Interventional Radiology : JVIR|October 21, 2000
Transjugular intrahepatic portosystemic shunts in the treatment of refractory ascites: results in 48 consecutive patientsJ M Péron, K Barange, P Otal, et al.
British Journal of Clinical Pharmacology|May 1, 1996
Haemodynamic effects of molsidomine and propranolol in patients with cirrhosisJ M Combis, J P Vinel, P Badia, et al.
Journal of the American Society of Nephrology : JASN|December 16, 1998
Pharmacokinetics of alphaIFN-2b in chronic hepatitis C virus patients undergoing chronic hemodialysis or with normal renal function: clinical implicationsL Rostaing, E Chatelut, J L Payen, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1993
[Treatment of hemorrhages by rupture of cardio-tuberous varices with transjugular intrahepatic portasystemic shunt]P Kuradusenge, H Rousseau, J P Vinel, et al.
Hepatology (Baltimore, Md.)|October 26, 1999
Transjugular intrahepatic portosystemic shunt in the treatment of refractory bleeding from ruptured gastric varicesK Barange, J M Péron, K Imani, et al.
Journal of Medical Virology|March 13, 1998
Baseline level and early suppression of serum HCV RNA for predicting sustained complete response to alpha-interferon therapyJ Izopet, J L Payen, L Alric, et al.
Gut|April 1, 1993
Diffuse vascular ectasia of the antrum, duodenum, and jejunum in a patient with nodular regenerative hyperplasia. Lack of response to portosystemic shunt or gastrectomyP Calès, J J Voigt, J L Payen, et al.
Journal of Hepatology|August 1, 1993
Hemodynamic and pharmacokinetic study of tertatolol in patients with alcoholic cirrhosis and portal hypertensionP Calès, H Caillau, O Crambes, et al.
Hepatology (Baltimore, Md.)|June 1, 1991
Systemic and splanchnic hemodynamic effects of molsidomine in rats with carbon tetrachloride-induced cirrhosisH Desmorat, J P Vinel, O Lahlou, et al.
Gastroenterology|November 14, 1997
Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infectionL Alric, M Fort, J Izopet, et al.
Pageof 6